2-71612672-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP3BP4_Moderate
The NM_001130987.2(DYSF):āc.4253C>Gā(p.Pro1418Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000378 in 1,614,178 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1418A) has been classified as Uncertain significance.
Frequency
Consequence
NM_001130987.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DYSF | NM_001130987.2 | c.4253C>G | p.Pro1418Arg | missense_variant | 39/56 | ENST00000410020.8 | |
DYSF | NM_003494.4 | c.4199C>G | p.Pro1400Arg | missense_variant | 39/55 | ENST00000258104.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DYSF | ENST00000410020.8 | c.4253C>G | p.Pro1418Arg | missense_variant | 39/56 | 1 | NM_001130987.2 | A1 | |
DYSF | ENST00000258104.8 | c.4199C>G | p.Pro1400Arg | missense_variant | 39/55 | 1 | NM_003494.4 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000485 AC: 122AN: 251302Hom.: 0 AF XY: 0.000486 AC XY: 66AN XY: 135848
GnomAD4 exome AF: 0.000374 AC: 547AN: 1461848Hom.: 1 Cov.: 31 AF XY: 0.000356 AC XY: 259AN XY: 727228
GnomAD4 genome AF: 0.000414 AC: 63AN: 152330Hom.: 0 Cov.: 33 AF XY: 0.000550 AC XY: 41AN XY: 74494
ClinVar
Submissions by phenotype
not provided Uncertain:6
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 06, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24438169) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Blueprint Genetics | Jun 12, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 04, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 19, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 29, 2023 | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2B Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Jan 31, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Qualitative or quantitative defects of dysferlin Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 10, 2023 | - - |
Miyoshi muscular dystrophy 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | May 18, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at